65,437 trials
Major Depressive Disorder
Primary: Change From Baseline in Montgomery-Åsberg Depression Rating Scale (MADRS) Total Score to Week 8 — -12.37; -15.03; -15.45 Scores on a scale — p=0.0080
Heart Failure
Primary: All Cause Mortality — 54.8; 64.8 percentage of participants — p=0.007
Osteosarcoma
Primary: Number of AEs Per Severity (All Courses) — 40; 27; 8; 15 Number of AEs
Healthy Adult Participants
Primary: AUClast: Area Under the Plasma Concentration-Time Curve From Time 0 to the Last Quantifiable Time Point of Unchanged Lu AA21004 — 299.3; 301.1 hour*nanogram per…
Alcohol Use · Drug Use
Primary: Number of Times Used Alcohol — 5.64; 5.18 score on a scale
Rheumatoid Arthritis · Musculoskeletal and Connective Tissue Diseases
Primary: Association Between Baseline Hand and Wrist Synovitis Rheumatoid Arthritis Magnetic Resonance Imaging Scoring System (RAMRIS) Score and Flare up to Week 40 in the…
Narcolepsy · Obstructive Sleep Apnea
Primary: Change in Epworth Sleepiness Scale (ESS) Score — 1.6; 5.3 points on a scale
Prehypertension · Hypertension
Primary: Heart Rate — 64; 71; 69; 58 bpm
Caregivers of Alzheimer's Disease or Memory Problem Patients
Primary: Depression as Measured by Center for Epidemiologic Studies Depression Scale (CES-D) — 11.38; 10.88; 10.86; 10.69 score on a scale
Stress Disorder, Post Traumatic
Primary: Galvanic Skin Response — .37; .29; .36 Unitless
Anemia
Primary: Accuracy of Noninvasive Hemoglobin (SpHb) Measurement by Arms Calculation — 0.93 g/dL
Infection
Primary: Number of Participants With Post-biopsy Infection. — 6; 3 participants — p=<0.05
Attention Deficit Hyperactivity Disorder
Primary: Plasma Concentrations of d- and L-amphetamine — 0; 0; 3.5; 1.1 ng/mL
Age-related Macular Degeneration · Diabetic Macular Edema · Injection Site
Primary: Number of Study Participants With Positive Conjunctival Culture — 1; 1 Participants — p=0.28
Atrial Septal Defect
Primary: Percent of Subjects With Two-year Device-related Hemodynamic Compromise — 0.65 percentage of participants